In light of this, the current study aims to investigate if immunometabolites known as regulators of the inflammasome/IL-1-family cytokine axis also participate in the altered inflammatory response of these patients with severe psychiatric disorders. The gene discussed is IL1B; the disease is psychiatric disorder.